Literature DB >> 14571107

Genetics of inflammatory bowel diseases--past, present, and future.

A S Peña1.   

Abstract

In this review, the evidence to support the multifactorial and polygenic nature of the disease is briefly described. The past of genetics of inflammatory bowel disease (IBD) is characterized by unfulfilled promises and is now closed with a new vision and a new promise coming from a genetic epidemiology approach. The genome-wide screening has led to the first gene of IBD and has given a new insight into the regulation of chronic inflammation. The future of IBD will be under scrutiny of the visionaries, but also the skeptics and the enthusiasts. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14571107     DOI: 10.1159/000073241

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  3 in total

1.  Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Authors:  Laszlo Lakatos; Gabor Mester; Zsuzsanna Erdelyi; Mihaly Balogh; Istvan Szipocs; Gyorgy Kamaras; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.

Authors:  Maria Gazouli; Gerassimos Mantzaris; Athanassios Kotsinas; Panayotis Zacharatos; Efstathios Papalambros; Athanassios Archimandritis; John Ikonomopoulos; Vassilis-G Gorgoulis
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

3.  No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.

Authors:  M van der Paardt; J B A Crusius; M H M T de Koning; S A Morré; R J van de Stadt; B A C Dijkmans; A S Peña; I E van der Horst-Bruinsma
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.